Insomnia treatment: paradigm shift
R.V. Buzunov
Central State Medical Academy, Moscow
The article is devoted to the issues of somnology and sleep disorders treatment. Cognitive behavioral therapy for insomnia (CBT-I) allows completely eliminating or significantly alleviating chronic insomnia in approximately 80% of patients. The aim of this article is to motivate change in medical thinking stereotypes. The author has set himself a rather ambitious task — to convince readers to take a fresh look at the problem of chronic development formation and insomnia progression into a chronic form. Thousands of articles and dozens of monographs on this topic have already been published. The problem consists of less as the lack of information or evidence, and more as simplified thinking stereotypes and the lack of physicians attention to this topic. In chronic insomnia, frontline treatment should be CBT-I. If it is ineffective or unavailable, drug therapy is used. What is more, when a patient complains about lack of sleep or sleep disorder, it is necessary to provide an early and intensive acute insomnia treatment, which should include both CBT-I elements and properly selected drug therapy in order to prevent chronic insomnia, taking into account the current data.
Keywords: sleep disorders, cognitive behavioral therapy, insomnia treatment, doxylamine, Donormyl®.
For citation: Buzunov R.V. Insomnia treatment: paradigm shift. RMJ. Medical Review. 2019;4(II):–86.
References
1. Shepard J.W. Jr, Buysse D.J., Chesson A.L. Jr. et al. History of the Development of Sleep Medicine in the United States. J Clin Sleep Med. 2005;1(1):61–82.
2. Sateia M.J., Buysse D.J., Krystal A.D. et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349. DOI: 10.5664/jcsm.6470.
3. Riemann D., Baglioni C., Bassetti C. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. DOI: 10.1111/jsr.12594.
4. Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management. Curr Med Res Opin. 2006;22(7):1257–1268.
5. Spielman A., Caruso L., Glovinsky P. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–553.
6. Licata S.C., Rowlett J.K. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90(1):74–89.
7. Ellis J.G., Cushing T., Germain A. Treating acute insomnia: a randomized controlled trial of a “single-shot” of cognitive behavioral therapy for insomnia. Sleep. 2015;38:971–978.
8. Инструкция по применению лекарственного препарата Донормил®. (Электронный ресурс). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5f6b62c7-fd5a-4f9a-a9a5–946d313ffea0andt= (дата обращения: 25.03.2019). [Instruction for use of the drug Donormil®. (Electronic resource). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5f6b62c7-fd5a-4f9a-a9a5–946d313ffea0andt= (access date: 25.03.2019) (in Russ.)].
9. Инструкция по применению лекарственного препарата Мелаксен. (Электронный ресурс). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=906d1aaf-373c-4f0b-8589–15ceadab9935andt= (access date: 25.03.2019) (in Russ.)].
10. Артюхова М.Г., Шанаева И.А. Структура и особенности лечения нарушений сна у больных сердечно-сосудистыми заболеваниями. РМЖ. 2010;26:1573. [Artyukhova M.G., Shanaeva I.A. The structure and characteristics of the treatment of sleep disorders in patients with cardiovascular diseases. RMJ. 2010;26:1573 (in Russ.)].
11. Полуэктов М.Г. Инсомния и расстройства дыхания во сне: возможности коррекции. РМЖ. 2011;15:948. [Poluektov M.G. Insomnia and sleep disorders in sleep: the possibility of correction. RMJ. 2011;15:948 (in Russ.)].
12. Ковров Г.В., Воробьева О.В. Нарушение сна: от жалобы к диагностике и лечению. РМЖ. 2006;6:439. [Kovrov G.V., Vorobieva O.V. Sleep disturbance: from complaints to diagnosis and treatment. RMJ. 2006;6:439 (in Russ.)].
2. Sateia M.J., Buysse D.J., Krystal A.D. et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349. DOI: 10.5664/jcsm.6470.
3. Riemann D., Baglioni C., Bassetti C. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. DOI: 10.1111/jsr.12594.
4. Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management. Curr Med Res Opin. 2006;22(7):1257–1268.
5. Spielman A., Caruso L., Glovinsky P. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–553.
6. Licata S.C., Rowlett J.K. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90(1):74–89.
7. Ellis J.G., Cushing T., Germain A. Treating acute insomnia: a randomized controlled trial of a “single-shot” of cognitive behavioral therapy for insomnia. Sleep. 2015;38:971–978.
8. Инструкция по применению лекарственного препарата Донормил®. (Электронный ресурс). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5f6b62c7-fd5a-4f9a-a9a5–946d313ffea0andt= (дата обращения: 25.03.2019). [Instruction for use of the drug Donormil®. (Electronic resource). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5f6b62c7-fd5a-4f9a-a9a5–946d313ffea0andt= (access date: 25.03.2019) (in Russ.)].
9. Инструкция по применению лекарственного препарата Мелаксен. (Электронный ресурс). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=906d1aaf-373c-4f0b-8589–15ceadab9935andt= (access date: 25.03.2019) (in Russ.)].
10. Артюхова М.Г., Шанаева И.А. Структура и особенности лечения нарушений сна у больных сердечно-сосудистыми заболеваниями. РМЖ. 2010;26:1573. [Artyukhova M.G., Shanaeva I.A. The structure and characteristics of the treatment of sleep disorders in patients with cardiovascular diseases. RMJ. 2010;26:1573 (in Russ.)].
11. Полуэктов М.Г. Инсомния и расстройства дыхания во сне: возможности коррекции. РМЖ. 2011;15:948. [Poluektov M.G. Insomnia and sleep disorders in sleep: the possibility of correction. RMJ. 2011;15:948 (in Russ.)].
12. Ковров Г.В., Воробьева О.В. Нарушение сна: от жалобы к диагностике и лечению. РМЖ. 2006;6:439. [Kovrov G.V., Vorobieva O.V. Sleep disturbance: from complaints to diagnosis and treatment. RMJ. 2006;6:439 (in Russ.)].
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
